title: Erythropoietin levels in children and adolescents with inflammatory bowel disease.
abstract: Iron deficiency anemia (IDA) and anemia of chronic disease (CDA) are often encountered in patients with inflammatory bowel disease (IBD). Inadequate intake or loss of iron is a clear cause of IDA, but mechanisms of CDA induction are multifactorial and involve erythropoiesis disturbance due to circulating inflammation mediators. The authors investigated erythropoietin (Epo) levels in children and adolescents with IBD and correlated them to disease activity, with the aim of gaining an improved understanding of the role of Epo in CDA. Thirty-three patients with IBD were examined (18 boys, 15 girls) ages 4 to 15 years (median 11 years). Two study groups related to the disease activity were formed: group A, those with active disease (n = 21), and group B, those in remission (n = 12). Epo levels were measured using a two-site chemiluminescence immunoassay. Predictive Epo values in response to the degree of anemia were calculated by the equation: logEpo = (3.48 - 0.20) x Hb. According to the results, CDA anemia was present only in patients with active disease. These patients also had a significantly higher possibility of altered Epo levels than expected compared with patients with inactive disease (16/21 vs. 4/12, P < 0.05). It was also interesting that most of the patients with anomalous Epo concentrations presented with an elevated Epo value compared with that expected from the calculation (14/20). It seems that disturbed Epo concentrations are correlated with disease activity in children and adolescents with IBD. It is possible that failure of the bone marrow to respond to increased Epo levels leads to further incremental response. These in turn lead to the high Epo concentrations detected in most of the authors' patients. Impaired Epo production is another mechanism of CDA development and is the one mainly expressed in patients with low Epo values.
authors.affiliation: First Department of Pediatrics, Athens University Medical School, Athens, Greece.
authors.forename: Artemis
authors.initials: A
authors.lastname: Tsitsika
authors.forename: Alexandra
authors.initials: A
authors.lastname: Stamoulakatou
authors.forename: Yota
authors.initials: Y
authors.lastname: Kafritsa
authors.forename: George
authors.initials: G
authors.lastname: Paleologos
authors.forename: Ioanna
authors.initials: I
authors.lastname: Panayotou
authors.forename: Evangelos
authors.initials: E
authors.lastname: Premetis
authors.forename: Eleftheria
authors.initials: E
authors.lastname: Roma
authors.forename: Ioannis
authors.initials: I
authors.lastname: Papassotiriou
mesh_terms: D000293:Adolescent; D002648:Child; D018450:Disease Progression; D004921:Erythropoietin / Q000097:blood* / Q000494:pharmacology*; D005260:Female; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000503:physiopathology*; D011379:Prognosis
chemical_list: D004921:Erythropoietin